Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
Condition:   Opioid Overdose Interventions:   Combination Product: 16 mg naloxone AP003;   Combination Product: 8 mg naloxone NARCAN Nasal Spray Sponsor:   Emergent BioSolutions Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2022 Category: Research Source Type: clinical trials